SAN FRANCISCO--(BUSINESS WIRE)--SanBio, a leading regenerative medicine company focused on the discovery and development of cell-based biologics, today announced that senior scientist, Yaisa Andrews-Zwilling, Ph.D., will give a presentation at the Women’s Intelligence Trust 2015 forum. The event will be held on April 30 at the St. Francis Yacht Club in San Francisco, Calif.
In her presentation, Dr. Andrews-Zwilling will discuss our world’s aging population and the need for increased stroke education, prevention and research. She will also address the growing need for chronic stroke therapies, of which there are currently none available, and give an overview of SanBio’s research and development in this area.
In its fifth year, the Women’s Intelligence Trust is a day-long forum meant to enhance the exchange of ideas and increase thought leadership opportunities for women in the areas of finance, health and technology. Women leaders will present cutting-edge research and ideas from their respective fields.
Said Dr. Andrews-Zwilling, “I am honored to participate in such an innovative program with women thought leaders with expertise spanning industries that are so critical to our future. I’m excited to share how the research and development we’re doing at SanBio is focused on making that future a healthier one for all of us.”
PRESENTATION
TITLE: Our Aging World, the Brain, and Stroke
WHEN:
Thursday, April 30
PRESENTED BY:
Yaisa Andrews-Zwilling, Ph.D., senior
scientist, SanBio
WHERE:
St. Francis Yacht Club
99 Yacht Road
San
Francisco, CA 94123
About SanBio
SanBio is a regenerative medicine company with
cell based products in various stages of research, development and
clinical trial testing. Its proprietary cell based product, SB623, is in
Stage 2 clinical trials for treatment of chronic stroke and is expected
to begin Stage 2 clinical trials for treatment of traumatic brain injury
later in 2015. Based in Tokyo, the company also has a United States
headquarters in San Francisco.